glp-1 clinical trials sign up Foundation GLP-1 therapies are powerful, but
Description
This is well characterized ( Tolhurst et al., 2012 )
& Isaacs, D
Importantly, GLP-1 injection into the ARC was shown to decrease the activity of agouti-related peptide (AgRP) neurons and their strong orexigenic effect and to activate the pro-opiomelanincortin (POMC) neurons, which are prominent in satiety via melanocortin pathways [50,55,56]
Updated on June 25th, 2026 Semaglutide can cause heart palpitations and a mildly increased pulse, typically raising resting heart rate by 2 to 4 beats per minute
No modifications to standard patient preparation protocols were made for these cases
